News
Mismatched unrelated donor stem-cell transplants achieved 80% survival at 1 year with post-transplant cyclophosphamide (PTCy) prophylaxis for GVHD. PTCy prophylaxis expands donor availability ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback